-
Thematic Analysis
NewPharma M&A Deals Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Pharma Sector
-
Sector Analysis
NewFuture of Pharma – Looking Ahead to 2024
This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors.
-
Product Insights
NewContinuous Positive Airway Pressure (CPAP) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A Continuous Positive Airway Pressure machine is used for the treatment of sleep apnea and in intensive care units as a form of ventilation. Continuous Positive Airway Pressure devices provide a gentle and unobstructed breathing by delivering a steady constant pressure of air through a hose which is connected to a nasal mask, nasal pillow or a full face mask. The mask must be carefully secured to the face so that no air escapes. This constant supply of air pressure...
-
Product Insights
NewSleep Apnea Diagnostic Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Sleep Apnea Diagnostic Systems Pipeline Market Report Overview Sleep Apnea Diagnostic Systems include polysomnography systems (PSG systems) used for the screening of sleep apnea. These include systems and devices used for the diagnosis of sleep apnea. One PSG system includes amplifiers, a hard disk, a monitor, a recorder, a laser printer, electrodes, cables, stands, stimulators, chest and abdomen respiration belts, and sensors. Fixed and portable polysomnography systems are tracked under this category. The Sleep Apnea Diagnostic Systems pipeline market report...
-
Sector Analysis
NewQatar Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Qatar Defense Market Report Overview In 2024, Qatar's defense budget is worth $14.4 billion. The country’s defense budget will grow at a CAGR of more than 6% during 2025-2029. The arms race in the Middle East region, modernization initiatives, the threat of Iranian missiles, and Qatar's diplomatic disputes are driving arms procurement in the country. Additionally, Qatar is spending billions of dollars to increase its military power, especially its air force capabilities. Amidst the ongoing diplomatic crisis, the country had...
-
Product Insights
NewChronic Lymphocytic Leukemia (CLL) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024" provides an overview of Chronic Lymphocytic Leukemia (CLL) Clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
NewSystemic Sclerosis (Scleroderma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024" provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Sclerosis (Scleroderma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
NewHospital Acquired Pneumonia (HAP) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
GlobalData's clinical trial report, “Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024" provides an overview of Hospital Acquired Pneumonia (HAP) Clinical trials scenario. This report provides top line data relating to the clinical trials on Hospital Acquired Pneumonia (HAP). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
NewNuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Nuclear Imaging Agents Market Report Overview The nuclear imaging agents market size was $998 million in 2023. Factors such as technical advancements and applied research will drive the market growth at a CAGR of more than 2% from 2023 to 2033. Nuclear imaging is a non-invasive medical technique that uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine, and neurological diseases. Nuclear Imaging Agents Market Outlook 2023-2033...